Henderson Michael Thomas

DirectorSpyre Therapeutics, Inc. (SYRE) · full profile →Form 4 · filed May 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.0M
Net Open-Market Flow
-$6.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2026Sell(S)2K$72.57$174K166K
May 8, 2026Sell(S)34K$73.72$2.5M133K
May 8, 2026Sell(S)25K$74.76$1.9M108K
May 8, 2026Sell(S)19K$75.35$1.5M89K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001636282-26-000053) within minutes of acceptance. Every field above traces to the original document. Verify it directly: